Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.

Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.

Ann Am Thorac Soc. 2015 Aug;12(8):1170-6. doi: 10.1513/AnnalsATS.201504-198OC.

2.

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.

Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9.

3.

Photoreactivity of a quantum dot-ruthenium nitrosyl conjugate.

Franco LP, Cicillini SA, Biazzotto JC, Schiavon MA, Mikhailovsky A, Burks P, Garcia J, Ford PC, da Silva RS.

J Phys Chem A. 2014 Dec 26;118(51):12184-91. doi: 10.1021/jp5111218. Epub 2014 Dec 15.

PMID:
25405612
4.

Nitric oxide releasing materials triggered by near-infrared excitation through tissue filters.

Burks PT, Garcia JV, GonzalezIrias R, Tillman JT, Niu M, Mikhailovsky AA, Zhang J, Zhang F, Ford PC.

J Am Chem Soc. 2013 Dec 4;135(48):18145-52. doi: 10.1021/ja408516w. Epub 2013 Nov 21.

5.

Photocatalytic carbon disulfide production via charge transfer quenching of quantum dots.

Bernt CM, Burks PT, DeMartino AW, Pierri AE, Levy ES, Zigler DF, Ford PC.

J Am Chem Soc. 2014 Feb 12;136(6):2192-5. doi: 10.1021/ja4083599. Epub 2013 Oct 29.

6.

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators.

Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.

7.

An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations.

Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, Bryce DA, Burks PA, Caraway DL, Calodney AK, Cash KA, Christo PJ, Cohen SP, Colson J, Conn A, Cordner H, Coubarous S, Datta S, Deer TR, Diwan S, Falco FJ, Fellows B, Geffert S, Grider JS, Gupta S, Hameed H, Hameed M, Hansen H, Helm S 2nd, Janata JW, Justiz R, Kaye AD, Lee M, Manchikanti KN, McManus CD, Onyewu O, Parr AT, Patel VB, Racz GB, Sehgal N, Sharma ML, Simopoulos TT, Singh V, Smith HS, Snook LT, Swicegood JR, Vallejo R, Ward SP, Wargo BW, Zhu J, Hirsch JA.

Pain Physician. 2013 Apr;16(2 Suppl):S49-283.

8.

Quantum dot photosensitizers. Interactions with transition metal centers.

Burks PT, Ford PC.

Dalton Trans. 2012 Nov 14;41(42):13030-42. doi: 10.1039/c2dt30465a. Review.

PMID:
23007191
9.

Quantum dot photoluminescence quenching by Cr(III) complexes. Photosensitized reactions and evidence for a FRET mechanism.

Burks PT, Ostrowski AD, Mikhailovsky AA, Chan EM, Wagenknecht PS, Ford PC.

J Am Chem Soc. 2012 Aug 15;134(32):13266-75. doi: 10.1021/ja300771w. Epub 2012 Aug 1.

PMID:
22808899
10.

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW; American Society of Interventional Pain Physicians.

Pain Physician. 2012 Jul;15(3 Suppl):S67-116.

11.

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.

Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW; American Society of Interventional Pain Physicians.

Pain Physician. 2012 Jul;15(3 Suppl):S1-65.

12.

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.

Rosenfeld M, Emerson J, McNamara S, Thompson V, Ramsey BW, Morgan W, Gibson RL; EPIC Study Group.

J Cyst Fibros. 2012 Sep;11(5):446-53. doi: 10.1016/j.jcf.2012.04.003. Epub 2012 May 1.

13.

Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families.

Miroballi Y, Garber E, Jia H, Zhou JJ, Alba L, Quittell LM, Angst D, Cabana M, Saiman L; CF Infection Control Study Consortium.

Pediatr Pulmonol. 2012 Feb;47(2):144-52. doi: 10.1002/ppul.21528. Epub 2011 Aug 24.

PMID:
22241572
14.

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.

Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW; EPIC Investigators.

Pediatr Pulmonol. 2012 Feb;47(2):125-34. doi: 10.1002/ppul.21525. Epub 2011 Aug 9.

15.

Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.

Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL; EPIC Study Group Participating Clinical Sites.

Pediatr Pulmonol. 2010 Sep;45(9):934-44. doi: 10.1002/ppul.21279.

PMID:
20597081
16.

FGF signalling modulates transcriptional repression by Xenopus groucho-related-4.

Burks PJ, Isaacs HV, Pownall ME.

Biol Cell. 2009 May;101(5):301-8. doi: 10.1042/BC20080136.

PMID:
18983265
17.

SOME PRACTICAL SUGGESTIONS REGARDING TESTIMONY OF MEDICAL EXPERTS.

Burks P.

Cal West Med. 1925 Jan;23(1):33-9. No abstract available.

Supplemental Content

Loading ...
Support Center